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1. INTRODUCTION 
 
1.1 Inflammation 
Inflammation is a protective process triggered by the immune response to traumatic, 
infectious, post-ischaemic, toxic or autoimmune injury in order to eradicate the 
offending agent and start the healing of the organism (Nathan C., 2002). It has been 
typified by “rubor, calor, dolor, tumor and functio lesa” (redness, heat, pain, 
swelling lost of function, Celsus AD40s) due to a complex set of mechanisms or 
reactions that involve the interaction between soluble factors, cells and vascular 
endothelium. In particular, resident macrophages, mast cells, vascular endothelial 
cells as well as dendritic cells represent the first line in the recognition of tissue 
damage or microbial infection. Upon stimulation they produce chemokines, 
cytokines and other inflammatory mediators such as lipid mediators (LM) or 
complement factors in order to amplify the inflammatory response. These mediators 
cause vasodilatation, increased vascular permeability (the leakage of fluid and 
proteins from blood vessels to the interstitial space) and recruitment of circulating 
leukocyte (especially neutrophils) to the inflamed situ (Dimasi et al.,2013). After the 
migration of the neutrophils towards the site of inflammation, they follow the chemo 
attractant flux and start their phagocytic activity. Then, neutrophils interact with 
epithelial cells, macrophages and endothelial cells and start to produce LM, which 
may exhibit “pro-inflammatory”, or “pro-resolving” activity (Wang et al., 2014). In 
fact, the production of anti inflammatory LM as well as of factors that promote the 
repairing of the damaged tissue render “acute inflammation” a self-resolving process. 
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On the contrary, the inflammatory reaction can also become excessive and lead to 
harmful outcomes such as tissue injury, fibrosis and angiogenesis (Medzhitov R., 
2008).  
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1.2 Eicosanoids 
1.2.1 Arachidonic acid cascade 
Cytosolic Phospholipase A (cPLA2) (EC: 3.1.1.4) is a lipolytic enzyme responsible 
for the release of Arachidonic Acid (AA, 5,8,11,14-eicosatetraenoic acid) from 
phospholipids. The translocation of this enzyme from the cytosol to the membrane is 
the essential regulatory step needed for its activation. This step can be mediated by 
the calcium increase as well as the phosphorylation on Ser-505 by MEK/ERK and 
p38 MAPK pathway (Gijòn M.A., 2000). When activated, cPLA2 catalyzes the 
hydrolysis of the sn-2 position of phosphatidylinositol and/or phosphatidilcoline (PC) 
to liberate AA.  
AA is a polyunsaturated fatty acid (PUFA 20:4 n-6) which has the essential role to be 
the precursor of eicosanoids (Capra et al., 2014; Funk CD., 2001).  
When AA is hydrolyzed from membrane phospholipid by PLA2 it can be substrate 
for three different enzymatic cascades: (I) cyclooxygenase (COXs) enzymes that lead 
to prostaglandins (PGs) generation; (II) 5-, 12-, and 15-lipoxygenase (LO) for 
production of (LTs), lipoxins (LXs) and related hydroxylated AA metabolites; (III) 
CYP450 oxygenase pathway for the formation of epoxyeicosatetraenoic acids 
(EETs) and diHETEs (Smith W.L., 1989).  Although most of the LM (such as LTB4 
and PGE2) act as “pro-inflammatory” factors, the metabolization of AA by 5-, 12-, 
and 15-LO can lead also to “pro-resolving” mediators like LXs (Fig.1). 
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    Fig.1 The Arachidonic Acid cascade (Nathan C. , Nature 2002). 
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1.2.1.1 5-Lipoxygenase 
5-Lipoxygenase (5-LO) (EC 1.13.11.34) is a dioxygenase with an estimated 
molecular mass of 72 to 80 kD first discovered in 1976. It is a key enzyme for LT 
biosynthesis expressed in several leukocytes such as: mast cells, 
monocyte/macrophages, polymorphonuclear leukocyte, dendritic cells and B 
lymphocytes. Mammalian 5-LOs are monomeric enzymes with 672 or 673 amino 
acids and contain two domains: an N-terminal C2-like regulatory domain (β-
sandwich) and a C terminal catalytic domain (α-helices). 5-LO contains a non-heme 
iron in the active site, coordinated by His-367, His-372, His-550 and the C- terminal 
Ile, that acts as an electron acceptor or donator during catalysis (Rådmark O., 1995). 
The ferrous state (Fe2+) consists in the inactive enzyme, while the ferric (Fe3+) one, in 
the active enzyme. After activation the ferric 5-LO uses a reductive agent to re-
establish the ferrous form (Chasteen et al., 1993; Hammarberg et al., 2001). 
5-LO has two catalytic functions: an oxygenase activity that corresponds to the 
addition of oxygen molecules to AA and the subsequent formation of 5-
hydroperoxyeicosatetraenoic acid (5-HPETE) and an epoxyde activity that leads to 
the formation of LTA4 (unstable epoxyde). 5-HPETE can be also substrate of 
glutathione peroxidases and reduced to alcohol 5-hydroxyeicosatetraenoic acid (5-
HETE). The unstable LTA4 can be then converted in LTB4 by stereo specific 
hydrolysis made by LTA4-hydrolase or conjugate with gluthatione forming LTC4, by 
LTC4-synthase. The consecutive cleavage of the glutathione tripeptide leads to the 
other cysteinil LT (cysLT): LTD4 (through the depletion of Υ-glutamyl residue by the 
Υ-glutamyltranferase) and LTE4 (after the elimination of glycine residue by 
dipeptidase) (Rådmark, et  al.,2014) Fig. 2. In LT biosynthesis plays an interesting 
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role also the communication between immune cells. In particular, has been shown by 
McGee and Fitzpatrick that erythrocytes, cells which are not suppose to synthesize 
any 5-LO product, when are co-incubated with neutrophils, produce LTA4 hydrolase 
that leads to a LTB4 production (starting from LTA4 produced in neutrophils) much 
higher then neutrophils alone. (McGee and Fitzpatrick, 1986). Furthermore, LTC4 
formation due to an intercellular transfer of LTA4 from neutrophils to the endotelium 
has been also proved.  (Feinmark and Cannon, 1986).  
In addition to AA, 5-LO can metabolize (oxygenase activity) other PUFAs such as 
5,8,11,14,17-eicosapentaenoic acid (EPA) leading to the formation of other pro-
inflammatory mediators such as 5-Hydroxyeicosapentaenoic acid (5-HEPE) or can 
convert Docosahexaenoic acid (DHA) in pro-resolving mediators like D-resolvins .  
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Fig.2 The leukotriene synthetic pathway (Werz O., 2002). 
 
"
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1.2.1.2 Regulation of 5-Lipoxygenase 
LT biosynthesis is a multistep process tightly regulated at different levels and by 
several mechanisms (Werz O., 2002):   
I) interaction of 5-LO with other proteins;  
II) binding of 5-LO  with small molecules, phospholipids and glycerides; 
III) phosphorylation of 5-LO;  
IV) intracellular localization of 5-LO. 
 
I)  Essentially, two proteins interact with 5-LO and modulate its activity: 
“coactosine-like protein” (CLP) and “5-LO activating protein” (FLAP).  
CLP is a protein part of ADF/Cofilin group, which promotes actin 
polymerization. It binds 5-LO to the C2-Like domain and the association of 
these two proteins was proved by the similar migration patterns in Mono Mac 
cells as well as in neutrophils. Though CLP is not able to activate 5-LO alone, 
it can support Ca2+ activation of the enzyme leading to the formation of 5-
HETE in absence of PC or working as a scaffold for the Ca2+ activated 
enzyme. When CLP is in combination with PC, the production of LTA4 
increases 3-4 folds. Moreover, it stabilize 5-LO enzyme and prevents its non-
turnover inactivation (Basavarajappa et al., 2014, Esser et al., 2009, Provost 
et al., 2001).  
The 5-LO activating protein “FLAP” (“Five Lipoxygenase Activating 
Protein”) plays a pivotal role in the availability of the substrate and the 
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efficiency of 5-LO enzyme. FLAP is a 18kDa protein which is a member of 
the membrane-associated proteins in eicosanoid-and glutathione metabolism 
superfamily (MAPEG). This protein is essential for the production of LTs by 
5-LO, without the FLAP activity there is no production of LTs. To date an 
indole-class of compounds, which inhibits selectively FLAP and, 
consequentially, LT production, has been identified. MK886 represents the 
first molecule identified by scientists at Merck-Frosst on 1986s, then, was 
individualized also a quinolone derived class with similar properties (Evans, 
et al., 2008).  
II)  Among small molecules, the effect of Ca2+ and ATP on 5-LO activity are the 
most studied. In particular, LT biosynthesis was observed after stimulation of 
neutrophils by Ca2+ ionophore (Samulesson, 1979), suggesting that the 
intracellular concentration of this divalent cation in the cell is relevant for 5-
LO activity. Ca2+ binds to the N-terminal C2-like β-sandwich domain which 
is a hydrophobic phospholipid-binding present also in cPLA2, thus this cation 
plays an important role in the translocation of these enzymes to the nuclear 
envelope (Rouzer and Samuelsson, 1987). Also Mg2+ is able to activate 5-LO 
in vitro (Reddy et al., 2000).  
ATP represents another small molecule able to activate 5-LO. It has a direct 
binding on 5-LO and it has been shown that its stimulatory activity is strictly 
related to the number of phosphate in the molecule (AMP<ADP<ATP) (Werz 
et al., 2002a) 
Membrane phospholipids have shown the function to increase 5-LO activity. 
In particular, PC is required for both basal and Ca2+ stimulated 5-LO activity 
in vitro (Skorey and Gresser,1998). 
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In addition to phospholipids, also glycerides could augment the catalysis of 5-
LO in vitro also in absence of Ca2+. In fact, it has been shown that the 
inhibition of the diacylglycerol-forming pathway involving phospholipase D 
(PLD) and phosphatidic acid phosphatase (PA-P) decreased 5-LO product 
synthesis as well as 5-LO translocation (Albertet al., 2008). Moreover, 
recently, a sex-related PLD activity has been shown in human monocytes 
with a consequent different LT production in male and female monocytes 
(Pergola  et al., 2011). 
 
III) 5-LO can be phosphorylated at three residues: a) Ser-271, by MAPKAP 
kinases; b)Ser-663 by ERK2; c)Ser-523 by Protein Kinase (PK)A catalytic 
subunit. 
The phosphorylation status can influence not only its activation but also 
regulate the subcellular localization of this enzyme. In fact, the 
phosphorylation at Ser-271 and Ser-663 increase LT production in 
neutrophils, monocytes and lymphocytes B in presence or in absence of 
intracellular Ca2+increment. On the contrary, phosphorylation to Ser-523 by 
PKA corresponds to a loss of 5-LO function.  
 
IV)  5-LO is considered “a mobile enzyme” for its characteristic to migrate in the 
cell from the cytosolic fraction to the nuclear one, after stimulation. This 
event is strictly related to LT formation. In resting condition, this enzyme is 
located in the cytosol or in the nucleoplasm of the cell depending from the 
cell type, the phosphorylation status and the sex. In fact recently, it has been 
shown that 5-LO subcellular localization differs in male and female 
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neutrophils, in resting condition. In particular, in these cells, androgen causes 
a perinuclear localization of 5-LO due to ERK and, consequentially, a lower 
formation of 5-LO products after stimulation (Pergola et al., 2008) Fig. 3. 
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Fig. 3 5-LO activation in the cells. In the resting cell, 5-LO is localized in either the 
cytosol or a soluble compartment inside the nucleus. On activation, 5-LO migrates to the 
nuclear envelope, where cPLA2 and FLAP aid 5-LO in LT biosynthesis. cPLA2 liberates AA 
from phospholipids. Membrane-bound FLAP is thought to facilitate the transfer of AA to 5-
LO. CLP can bind 5-LO. Nuclear import sequences (NIS) in the 5-LO sequence determine 
import into the nucleus. Stimuli of LT biosynthesis lead to an increase in Ca2+ and/or 
activation of MAPK. When 5-LO is activated, the iron is oxidized by LOOH from Fe2+ to 
Fe3+. In 5-LO, Ser271 is phosphorylated by MK-2/3 downstream of p38 MAPK. ERK 
phosphorylates 5-LO on Ser663. An increase in cAMP levels activates PKA, which represses 
5-LO activity through phosphorylation on Ser523 (Radmark, O. et al., 2007)  
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1.2.1.3 Physiopathological role of Leukotrienes 
 
LT are lipid mediators involved in several immune/inflammatory related diseases. 
They act through the G protein-coupled receptors that are located on the outer plasma 
membrane of structural and inflammatory cells leading to different biological 
functions (e.g., smooth muscle cell contraction and neutrophil chemotaxis). In 
particular, LTB4 and cys-LT have different receptors. There are two known receptors 
for LTB4: the high affinity B leukotriene 1 receptor (BLT1) mainly expressed in 
leukocytes (Yokomizo et al., 1997) and the lower affinity (20 fold lower than BLT1 
due to its affinity for 12- and 15-HETE) BLT2 receptor ubiquitously expressed.  but 
its physiological activity are still unknown (Yokomizo et al.,  2000-2001). 
Concerning cys-LT receptors, to date at least two receptors are identified: cys-LT1 
and cys-LT2. The first is the most studied one. It is expressed on a variety of both 
immune-competent cells and structural cells. Results with cys-LT1 antagonists both 
in clinical studies and in animal models of asthma suggest that many of the features 
of asthma (eosinophilic airway inflammation, bronchoconstriction, edema, goblet 
cell hyperplasia, and structural remodeling of the airway) are mediated by cys-LT1 
signaling (Peters-Golden, Henderson WR Jr, 2007). The cys-LTs–cysLT1 pathway 
is also implicated in the pathogenesis of allergic rhinitis (Peters-Golden , et al., 
2006).! Cys-LT2 is co-expressed with cys-LT1 in many cell types including 
endothelium, eosinophils, mast cells, and macrophages. Although its role in immune-
competent cells remains unclear, it has been studied for its important role on vascular 
permeability mediation (Beller et al., 2004). CysLT1 as well as 5-LO are important 
target for the treatment of asthma. In particular, montelukast, zafirlukast and 
pranlukast (cys-LT1 inhibitors) are available for clinical treatment of asthma. Also a 
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5-LO inhibitor, zileuton, has been used in the treatment of this disease, however its 
availability is limited due to hepatotoxicity.  
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1.2.1.4 Cyclooxygenases 
 
Prostaglandins (PG) are not stored free in tissues, but are formed by the action of 
the COX, or prostaglandin endoperoxide synthase (PGHS) in a two-step conversion 
of AA. First, the enzyme converts AA to a cyclic endoperoxide (PGG2) by the 
action of cyclooxygenase (COX) activity adding the 15-hydroperoxy group. The 
hydroperoxy group of PGG2 is reduced to the hydroxy group of PGH2 by a 
peroxidase that uses a wide variety of compounds to provide the requisite pair of 
electrons. Both cyclooxygenase and hydroperoxidase activities are contained in the 
same dimeric protein molecule. These unstable intermediate products of AA 
metabolism by COX are then rapidly converted to the corresponding PG by specific 
isomerase enzyme, the nature of which is determined by the enzyme content of the 
tissue under consideration Fig 4.  
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Fig. 4 Cyclooxygenase pathway and prostanoids (Kawahara K. et al.,2015) 
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COX was first purified from the sheep seminal vesicle, a prodigious source of the 
protein (Miyamoto et al.,1976) as a homodimer of approximate molecular mass of 70 
kDa and subsequently cloned from the same tissue. COX is eme-dependent 
glycoprotein, is a dimer of identical subunits, so altogether, there are two 
cyclooxygenase active sites and two peroxidase active sites in close proximity. COX 
is embedded in the membrane of the nucleus and endoplasmatic reticulum of all 
mammalian cells except the erythrocytes. Ferrum atom in heme group is responsible 
of catalytic activity; in fact only when the ferrum is in the oxidation state III the 
COX is active. 
Initially, it was thought that COX was a single enzyme that produced PG in most 
tissues and cell types. However, a number of studies have illustrated that COX 
activity is increased in certain inflammatory states and is induced in cells by pro-
inflammatory cytokines and growth factors in vitro (Sano et al., 1995). Following 
these observations, extensive research in this field led to the discovery that two forms 
of COX exist, named COX-1 and COX-2. With the availability of the cDNA 
encoding the protein and specific antibodies, numerous studies were performed to 
evaluate the distribution, expression and regulation of the two COXs both in vitro 
and in vivo. The transcription of COX-1 yields a 2.7-kilobase (kb) mRNA that 
encodes a 576-residue, 65-kd protein. Conversely, the transcription of COX-2 yields 
a 4.5-kb mRNA that encodes a 70-kd protein with roughly 70-75% homology to the 
COX-1 protein. Using sequence analysis of human genomic DNA, researchers have 
concluded that the amino acids, important for catalysis by COX-1, are conserved and 
equally important for catalysis by COX-2. Evidences suggest that COX-1 and COX-
2 are similar in structure and function but exist as 2 distinct enzymatic entities. They 
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have been defined as monotropic integral membrane proteins located primarily in the 
endoplasmic reticulum (COX-1) and perinuclear envelope (COX-2) (Morita et al., 
1995).  
The constitutive isoform (COX-1) is present in tissues such as the stomach, gut or 
kidney, where PG production plays a cytoprotective role in maintaining normal 
physiological processes, such as: platelet aggregation inhibition, inhibition of platelet 
and neutrophil adhesion, dilation of bronchial and vascular smooth muscle (mediated 
by PGI2) and other effects mediated by PGE2 (described later). By contrast, the 
inducible isoform of COX (COX-2) is only constitutive in parts of the kidney, and 
brain, in fetal membrane and in the uterus during pregnancy. In all other tissues and 
cells, COX-2 is inducible by variety of mitogens, tumour promoters and pro-
inflammatory stimuli, including bacterial factors and cytokines. COX-2 is expressed 
in many cells including fibroblasts and macrophages. The COX-2 expression is 
regulated by mitogen-activated protein kinase (MAPK). They are a group of serine 
threonine kinases and the MAPK family in mammalian cells includes extracellular 
signal-regulated kinase-1 and –2 (Erk-1/2), the c-Jun NH2-terminal kinases (JNK) 
and p38 MAPK. Their actions on transcription factors, affect gene-regulated cellular 
responses by relaying growth, development, differentiation, and stress stimuli 
(Garrington et al., 1999).  
COX-2 releases large quantities of pro-inflammatory PG at the site of inflammation. 
PG mediate various manifestations of the inflammatory response, including fever, 
hyperalgesia, increase in vascular permeability and oedema. In the intestine, PG 
influence motility and secretion and they stimulate diarrhoea by promoting chloride 
secretion and blocking sodium absorption in epithelial cells (Sartor et al., 1991). PG 
are involved in a number of inflammatory conditions and diseases, such as arthritis, 
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skin inflammation where PG potentiate the inflammatory actions of platelet-
activating factor and asthma where PGD2 mediate bronchoconstriction (Henderson et 
al., 1991). 
Based on these differences, the concept of “pro-inflammatory COX-2” versus a 
“protective COX-1” rapidly emerged. However, in a model of carrageenan-induced 
pleurisy in rats it was concluded that COX-2 may be pro-inflammatory in early phase 
and may regulate resolution in the later phase of pleurisy, by generating an alternate 
set of PG such as those of the cyclopentenone family (PGD2 and 15deoxyΔ12-14PGJ2) 
(Gilroy et al., 1999).  
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1.2.1.5 Physiopathological role of PGE2 
Among PGs, PGE2 is involved in several classic signs of the inflammatory process 
such as vasodilatation and increased micro vascular permeability, moreover it is 
responsible also of the pain because of its activity on peripheral sensory neurons as 
well as central sites (Funk CD., 2001).  
PGE2 is synthesized from PGH2 by cytosolic PGE synthase (cPGES) or microsomal 
PGE synthase (mPGES-1 and mPGES-2) (Samuelsson et al., 2007). cPGES is 
constitutively and abundantly expressed in the cytosol of various tissues and cells 
and it requires glutathione as a cofactor (Tanioka et al., 2000). The role of cPGES 
and even its ability to form PGE2 is controversial. cPGES seems capable of 
converting COX-1-derived but not COX-2-derived PGH2 to PGE2 in cells, 
particularly during the immediate PGE2-biosynthetic response elicited by 
Ca2+evoked stimuli. mPGES-1 is a member of the membrane-associated proteins 
involved in eicosanoid and glutathione metabolism superfamily, and like cPGES, it 
requires glutathione as cofactor (Jakobsson et al., 1999). mPGES-1 is a peri-nuclear 
protein that is markedly induced by cytokines and growth factors and down-regulated 
by anti-inflammatory glucocorticoids, as in the case of COX-2 ( Mancini et al., 
2001;! Thorén et al., 2000). It is functionally coupled with COX-2 in marked 
preference to COX-1("Murakami et al., 2000).  Constitutive expression of mPGES-1 
in certain tissues and cell types was also reported. 
PGE2 acts through distinct G protein coupled receptors (EP-1-4) and mediate 
intracellular signals via cyclic nucleotide. EP-3 and 4 are the most expressed and 
represents the receptors with highest affinity for PGE2.This prostanoid can exert both 
pro-inflammatory and anti-inflammatory activity. In particular, the binding of PGE2 
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on EP-3 receptors on mast cell increases the vascular permeability as well as 
promotes leukocyte recruitment by induction of degranulation and IL-6 release. 
Moreover the binding of PGE2 to EP-4 receptor on T cells facilitates Th1 
differentiation and Th17 expansion (Kawahara et al., 2014). In addition to that, 
PGE2 can exert anti-inflammatory actions on innate immune cells, such as 
neutrophils, monocytes, and natural killer cells (Harris et al., 2002). 
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1.3 Sex-dependent differences in inflammatory diseases 
Accumulate evidences show the relevance of the sex-dependent differences in the 
immune and inflammatory diseases. In particular, the female prevalence in 
autoimmune diseases represents an important task for many researchers and 
industries. This sex-bias seems to affect their development as well as their incidence. 
In particular, it has been reported that only after puberty, female have a predominant 
incidence of asthma disease compared to male suggesting an important role of 
androgens (Zannolli and Morgese, 1997). Moreover multiple sclerosis (MS) has an 
important higher incidence and severity in female compared to male (Khalid R, 
2014). Also in animal models of MS, such as the Experimental Autoimmune 
Encephalomyelitis (EAE) in mice, sex-related differences are evident. In particular, 
Palaszynki et al., showed protective effects of androgens in this model. Female 
predominance has been also observed in systemic lupus erythematosus (SLE) and 
rheumatoid arthritis (RA) with female to male prevalence ratios of 7-9:1 for SLE and 
2-3:1 for RA (Tedeschi et al., 2013). LT plays a pivotal role in all of the mentioned 
disorders. Interestingly, it has been recently shown a sex-dependent difference in LT 
production in human blood immune cells. In particular, testosterone seems to exerts a 
protective role affecting 5-LO subcellular localization/activity in these cells with a 
consequent decreased LT biosynthesis. In fact, as described above, 5-LO subcellular 
localization as well as its phosphorylation by MAPK are crucial steps in LT 
biosynthesis. The mechanisms of action underlying this protective effect are, 
essentially, two: 
• First, in neutrophils and in human whole blood testosterone affects 5-LO 
compartmentalization via ERKs activation. In these cells, in resting condition, 
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5-LO enzyme is located mostly in the cytosolic fraction then, upon 
stimulation, it migrates to the perinuclear one producing LT. The 
testosterone-dependent basal activation of ERK, confines 5-LO to a 
perinuclear compartmentalization (which is not active) in resting condition 
leading to less amount of this enzyme in the cytosolic fraction able to migrate 
and produce LTs (Pergola et al., 2008). 
• Second, in monocytes, androgens cause ERK activation that leads to lower 
PLD activity (apparently attributable to the PLD1 isoform) and DAG levels, 
which are required for fully induced 5-LO activity and consequently LT 
biosynthesis  
These androgen-dependent sex differences call for in-depth analysis of the impact of 
sex and androgens on immune cell biology and related pathophysiological processes 
(Pergola et al., 2011). 
Intriguingly, also protective effect of female hormones in inflammatory diseases has 
been reported. In particular, as compared with age-matched men, pre-, but not post-, 
menopausal women have been shown to be protected against cardiovascular diseases, 
which may be associated with the vasoprotective and anti-inflammatory effects of 
estrogen (17b-estradiol) (Kannel et al., 1995). In addition to that, pre-menopausal 
women show a favorable prognosis of sepsis compared to men (Schröder et al., 
1995). Moreover, the ability of the estrogen to inhibit the expression of adhesion 
molecules in primary lung endothelial cells causes a lower neutrophil afflux in this 
tissue during inflammation (Villar et al., 2011). On these bases, the elucidation of the 
mechanisms underlying the protective role of both female and male hormones in 
eicosanoid-related diseases represents the main aim of the present investigation. 
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2. AIM OF THE PRESENT INVESTIGATION 
 
Eicosanoids, PGs and LTs, are key mediators of the inflammatory response. They 
are synthesized from AA through essentially two enzymes: COXs or 5-LO, 
respectively.  
Among PGs, PGE2 is the most ubiquitously produced PG under both 
physiological and pathophysiological conditions (Ushikubi et al., 2000; Narumiya S., 
2007) and is long known as an immunosuppressant for its inhibition of production of 
inflammatory cytokines by macrophages (Harris et al., 2007). Moreover PGE2 has 
shown immune-activator properties acting on the EP4 receptor (Sakata et al., 2010).  
Besides PGs also LTs plays different and pivotal roles in the 
immune/inflammatory process. In particular, LTB4 has strong chemotactic activity 
(Yokomizo et al., 1997) and cys-LT promote the smooth muscle cells contraction, 
activation of leukocytes and increase vascular permeability. Their biosynthesis is a 
thin regulated process which strictly depends on: a) interaction of 5-LO with other 
proteins (i.e FLAP); b) phosphorylation of 5-LO protein; c) subcellular localization 
of 5-LO. 
Sex-dependent difference in autoimmune/inflammatory diseases is at glance in the 
scientific community. In fact, there is a well-known sex-bias in asthma incidence 
which is clearly related to the changes in male hormones pre and after puberty 
(Zannolli et al., 1997). In addition to that, female are more susceptible to develop 
autoimmune diseases like multiple sclerosis (Khalid R., 2014). To date, little is 
known about the molecular reason of this sex difference. Recently, it has been 
demonstrated that the LT biosynthesis in human immune cells (monocytes, 
neutrophils and in the human whole blood) is sex-biased. In particular, these cells, 
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coming from male donors, produce less LT levels than the female, after in vitro 
stimulation (Pergola et al., 2008 and 2011). This difference in LT production is 
related to the effect of testosterone on 5-LO enzyme compartmentalization that 
affects its catalytic activity and this represents an important finding in the light of the 
well known sex-biased incidence of several immune diseases (i.e. asthma). 
Moreover, recently, a sex difference of 5-LO expression in the brain tissue of 
multiple sclerosis patients has been shown. In particular, there is an higher 
expression of this enzyme in female, but no data about LT levels are available to 
date. A beneficial effect by androgens has been observed also in other LT-related 
diseases, like atherosclerosis and cardiovascular diseases (CVD). In fact, although 
the incidence of these diseases is higher in males than in females, testosterone is a 
protective factor against atherosclerosis (Malkin et al., 2003), and men with coronary 
artery disease have lower levels of androgens than men with normal coronary 
angiograms (English et al., 2000). 
On the contrary, few is known about sex differences in PGE2 release, despite 
there is a sex bias in the incidence and in the outcomes of many 
inflammatory/autoimmune diseases PG- related (i.e. ulcerative colitis or sepsis 
Tragnone et al., 1996; Schroeder et al., 1998). 
In the light of these remarks, the aim of the present investigation was to evaluate 
the differences in eicosanoid biosynthesis in male and in female using in vivo models 
of acute inflammation. Moreover, in order to investigate the molecular mechanisms 
related to these differences, as in vitro system, we isolated the immune cells 
responsible of eicosanoid production. 
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3. MATERIALS AND METHODS 
 
3.1 Materials 
Nycoprep was from PAA Laboratories (Linz, Austria). Ca2+-ionophore A23187, AA, 
PGB1, and EDTA were from Sigma (Deisenhofen, Germany). Enzyme immunoassay 
(EIA) kits were from Cayman Chemical Company (Aurogene, Rome, Italy). [3H-
PGE2] was from PerkinElmer Life Sciences (Milan, Italy). All other reagents and 
compounds were obtained from Sigma–Aldrich (Milan, Italy). 
 
3.2 In vivo models of acute inflammation   
 
3.2.1 Animals 
Male and female CD-1 mice (8–9 weeks old, Charles River, Calco, Italy) and Wistar 
male and female rats (300 g, Harlan, Milan, Italy) were housed in a controlled 
environment (21±2◦C) and provided with standard rodent chow and water. All animals 
were allowed to acclimate for four days prior to experiments and were subjected to 12h 
light – 12h dark schedule. Experiments were conducted during the light phase.  
The experimental protocols were approved by the Animal Care Committee of the 
University of Naples Federico II in compliance with Italian regulations on protection of 
animals used for experimental and other scientific purpose (Ministerial Decree 116/92) 
as well as with the European Economic Community regulations (Official Journal of E.C. 
L 358/112/18/1986). 
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3.2.2 Zymosan-induced peritonitis in mice  
  
Zymosan-induced peritonitis in mice is a model of acute inflammation useful to study all 
the steps that characterize this process. In particular, zymosan injection in the peritoneal 
cavity of the mice induces the development of the typical hallmarks of the inflammatory 
process such as increased vascular permeability, oedema, leukocyte influx and release of 
inflammatory mediators (LT and PG).  
 
3.2.2.1 Induction of peritonitis  
 
Peritonitis was induced in mice by i.p. injection (0.5 mL) of zymosan (2 mg mL−1 in 
saline, boiled and washed; Sigma, Milan, Italy). At selected time points after zymosan 
injection (0, 15, 30, 60, 120, 180, 240, 360 and 480 min), mice were euthanized and 
peritoneal exudates were collected using 2 mL of phosphate buffered saline (PBS). The 
cells were counted using a light microscope in a Burker’s chamber after vital trypan blue 
staining. Exudates were centrifuged at 20,000 × g for 20 min at 4°C and supernatants and 
cell pellets were collected and frozen at −80 ◦ C for measurements of eicosanoids 
(supernatants) and the evaluation of myeloperoxidase (MPO) activity and western 
blotting analysis of protein expression (cells, see next paragraphs). In one set of 
experiments peritonitis was induced only in  female mice, according to what previously 
described, 30 min after the injection of 5α-dihydrotestosterone (0.5 mg kg-1 5α-DHT in 
2% DMSO) or  vehicle (DMSO 2% in saline). At selected time points after zymosan 
injection (0, 15, 30, 240 min), mice were euthanized and peritoneal exudates were 
collected using 2 mL of PBS and the supernatants of the peritoneal exudates were stored 
at -80°C for LT measurement (see next paragraphs).  
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3.2.2.2 Vascular permeability  
 
Evans blue dye (40 mg kg−1, 0.3 mL; Sigma, Milan, Italy) was injected into the tail vein 
followed by an i.p. injection of zymosan (0.5 mL; 2 mg mL−1). After 0, 15, 30, 60, 120, 
180 and 240 min, mice were euthanized and peritoneal exudates were collected using 
PBS (0.1 mL g−1 of body weight). After centrifugation, supernatants (diluted 1:3) were 
analyzed for Evans Blue bound to plasma albumin by reading at 610 nm in a plate reader 
(MultiskanGo, Thermo Scientific).  
 
3.2.2.3 Mieloperoxydase activity  
 
The use of Mieloperoxydase (MPO) activity, as an index of neutrophil infiltration, is 
well documented (Bradley et al.,1982) . Cell pellets were disrupted by sonication in 2 
mL PBS (50 mM, pH 6) with 0.5% hexadecyltrimethylammonium bromide, freeze-
thawed three times and centrifuged (32,000 × g, 20 min) to collect supernatants which 
were used in MPO assay, performed as described previously (Bradley et al.,1982) .. 
Briefly, 20 µL of samples were added to a 96 well plate and the reaction was initiated by 
the addition of 0.2 mL of assay buffer containing 0.167 mg mL−1 of o-dianisidine and 
0.0005% hydrogen peroxide. The rate of change of absorbance was monitored in kinetic 
mode by a plate reader (IMarkmicroplate Reader, Bio-Rad, Segrate, Milan, Italy). Levels 
of MPO in samples were determined from the calibration curve using human neutrophil 
MPO as reference standard. The levels of MPO were expressed as U mL−1.  
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3.2.2.4 Blood collection and plasma preparation 
 
Blood was collected by intracardiac puncture immediatly after killing mice with CO2. In 
particular, the puncture was made through the insertion of 1mL syringe with a needle of 
22 gauge in the heart. Plasma was obtained by centrifugation of the whole blood (597 x g 
at 4 °C, 15 minutes). 
Plasma testosterone was measured with a commercially available KIT EIA (Cayman 
Chemical Company,Aurogene, Rome, Italy). 
 
3.2.2.5 Mouse gonadectomy 
 
To investigate the impact of sex hormones, male mice were orchidectomized (ORCH 
group) and allowed to recover for 5 weeks. This time period ensures the metabolization 
of sex hormones so that they are no longer in the blood, and it is sufficient to allow the 
turnover of immune cells generated under the influence of this reproductive hormone 
(Rettew et al., 2008; Scotland et al., 2011) . In particular, orchidectomy was performed 
through scrotal incision. Sham groups were performed through the similar procedures, 
except that the gonads were not removed. After 5 weeks, peritonitis was induced as 
previously reported and mice were sacrificed at 15 or 30 min (the peak time) for the 
measurement of LTC4 or LTB4 in the exudates, respectively.  
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3.2.2.6 Determination of 5-LO and COX products 
 
The peritoneal exudate levels of LTC4, LTB4 were measured by EIA kits according to 
manufacturer’s instructions (Cayman Chemical; Aurogene, Rome, Italy), while PGE2 by 
radioimmunoassay (RIA) (PerkinElmer Life Sciences, Milan, Italy; Sigma, Milan, Italy) 
and expressed as ng mL−1. 
In one set of experiments, the amount of LTs content in the exudates was measured by 
ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) 
analysis in Prof. Oliver Werz’s laboratory at the Department of Pharmacy of the 
“Friederich Schiller Universitaet” of Jena, Germany. In particular the supernatants of 
peritoneal exudates were extracted by solid phase extraction on RP18-columns 
containing a polymeric reversed phase after conditioning the column with 1 ml 100% 
methanol and 1 mL H2O. After washing the columns two times with 0.5 mL H2O, 
eicosanoids were eluted with 300 µL 100% methanol. UPLC-MS/MS analyses were 
carried out on an Acquity UPLC BEH C18 column (1.7 µm, 2.1×50 mm, Waters, 
Milford, MA, USA) using an AcquityTM UPLC system (Waters) and a QTRAP 5500 
Mass Spectrometer (AB Sciex, Darmstadt, Germany) equipped with a Turbo V™ Source 
and electrospray ionization (ESI) probe. Automatic peak integration were performed 
with Analyst 1.6 software (AB Sciex, Darmstadt, Germany) using Intelli Quan default 
settings. Data were normalized on the internal standard PGB1. 
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3.2.2.7 Preparation of total cell lysates 
 
Total cell lysates were prepared by lysis for 15 min at 4°C with lysis buffer (20 mM 
HEPES, pH 7.6, 1.5 mM MgCl2, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 
1 mM phenylmethanesulfonyl fluoride (PMSF), 15 µg mL−1 soybean trypsin inhibitor, 3 
µg mL−1 pepstatin A, 2 µg mL−1 leupeptin, 1% Nonidet P-40, 20% glycerol, 50 mM 
NaF). Lysates were centrifuged (12 000 xg, 15 min 4°C), the supernatants were collected 
and stored at -80 °C.  
 
3.2.2.8 Western blotting analysis 
 
Protein concentration was determined by Bio-Rad Protein Assay (Bio-Rad Laboratories, 
Segrate, Milan, Italy). The samples were mixed with 4X gel loading buffer (250 mM 
Tris, 8% SDS, 40% glycerol, 20% 2-mercaptoethanol, 10 mg mL-1 of bromophenol 
blue), heated for 6 min at 95°C. Each sample was loaded and analyzed by 
electrophoresis on a 10% SDS-polyacrylamide gel. Correct loading of the gel and 
transfer of proteins to the nitrocellulose membrane was confirmed by Ponceau staining. 
After electroblot to nitrocellulose membrane (Whatman Protran, Dassel, Germany), 
membranes were blocked with 0.1 % PBS/Tween containing 5% Milk for 1 hour at room 
temperature. Membranes were washed and then incubated with primary antibody 
overnight at 4°C. COX-1, COX-2 (Cell Signalling, Aurogene, Rome, Italy) and β-actin 
antibodies were used as 1:1000 dilution. After the incubation, the membranes were 
washed six times with 0.1% PBS-Tween and were incubated for 1.5 h at room 
temperature with horseradish peroxidase-conjugated anti-rabbit and anti-mouse 
secondary antibodies diluted 1:10,000 in 0.1% PBS-Tween containing 5% non-fat dry 
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milk. The membranes were washed and protein bands were detected by an enhanced 
chemiluminescence system. 
 
3.2.2 Carrageenan-induced pleurisy in rats    
 
Rats were anesthetized with 4% enflurane mixed with 0.5 l/min O2, 0.5 l/min N2O and 
submitted to a skin incision at the level of the left sixth intercostal space. The underlying 
muscle was dissected, and saline (0.2 mL) or 1% (w v-1) λ-carrageenan type IV (0.2 mL) 
was injected into the pleural cavity. The skin incision was closed with a suture, and the 
animals were allowed to recover. At the selected time points (2-4-8 hours) after 
carrageenan injection, animals were sacrificed by CO2 inhalation. Pleural exudate was 
collected by injection in the cavity of 2mL of saline solution, after centrifugation (800 x 
g for 10 min) the cells were counted by Burcher´s chamber and supernatants were frozen 
at -80°C. In one set of experiment, rats were pre-treated with 1,5 mg/kg Mk886 
(Caymann- chemical, Aurogene, Rome, Italy) 30 minutes prior pleurisy induction. 
Animals were sacrificed 4 hours after pleurisy induction. The amount of PGE2 in the 
supernatant of centrifuged exudates was measured by RIA. Results are expressed as the 
total amount of PGE2 measured in the pleural exudate of one rat (nanograms per rat). 
 
3.2.3 PAF-induced shock in mice 
 
PAF C-16 was dissolved in chloroform and stored at -20°C. The PAF working solution 
was freshly prepared directly before use. To this aim, chloroform was evaporated under 
N2, and PAF was dissolved in 0.9% saline solution containing 0.25% bovine serum 
albumin. Mice were challenged with 30 µg kg-1; 100 µg kg-1; 200 µg kg-1 PAF in a 
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volume of 200 µL via a tail vein injection. Death (determined by cessation of breathing) 
was then recorded over a period of 2 h. All animals surviving the 2-h test session were 
euthanized by CO2 inhalation. 
 
3.3 In vitro models of inflammation   
 
3.3.1 Murine resident peritoneal macrophages   
 
3.3.1.1 Collection of resident peritoneal macrophages  
 
Resident peritoneal macrophages (PM) were obtained by lavage of the peritoneal cavity 
of female and male naive and sham mice or from ORCH mice with 7 mL of cold 
Dulbecco’s modified Eagle’s medium (DMEM) with heparin (5U mL−1). PM were then 
centrifuged at 500×g 4◦C for 5 min, resuspended at 1×107 cells mL−1 and 0.5 mL of cell 
suspension were added to a 15 mL conical polypropylene tube for each experimental 
condition. Cells were then incubated at 37◦C with ionophore A23187 (4.5 mL, final 
concentration 2.5µM, 15 min), zymosan (4.5 mL, final concentration 13 particles per 
cell, 30 min) or vehicle (0.25% dimethyl sulfoxide in DMEM for A23187 and DMEM 
for zymosan). EDTA at a final concentration of 4 mM was added at the end of 
incubation time to A23187-stimulated cells; in one set of the experiment, PM from 
female mice were pre-treated with 5α-DHT (10nM, 15 min, 37°C) and PM from male 
mice were pre-treated with β-estradiol (100nM,15 min, 37°C) piror stimulation. All 
samples were then centrifuged at 500 × g at 4 ◦ C for 5 min. Supernatants were collected 
and frozen at −80°C for measurements of LTC4 and PGE2 by EIA (Cayman Chemical 
Company; Aurogene, Rome, Italy) and RIA (PerkinElmer Life Sciences, Milan, Italy; 
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Sigma, Milan, Italy) respectively. The cell pellets were washed by resuspending in ice-
cold PBS, centrifuged and collected and frozen at −80°C for 5-LO evaluation.  
 
 
3.3.1.2 Preparation of cell lysates 
 
Total cell lysates were prepared as previously described (see paragraph 3.2.2.7).  
Subcellular fractionation was carried out by mild-detergent lysis (0.1% NP40) according 
to Werz and colleagues (Pergola et al., 2008). Isolated PM were suspended in ice-cold 
NP-40-lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 1 mM EDTA, 
0.1%NP-40, 1 mM PMSF, 60 µg mL-1 soybean trypsin inhibitor and 10 µg mL-1 
leupeptin), vortexed (3 × 5s), kept on ice for 10 min, and centrifuged (1250 µg, 10 min, 
4°C). Resultant supernatants (non-nuclear fractions) were transferred to a new tube 
whereas the pellets (nuclear fractions) were resuspended in ice-cold relaxation buffer (50 
mM Tris-HCl, pH 7.4,250 mM sucrose, 25 mM KCl, 5 mM MgCl2, 1 mM EDTA, 1 mM 
PMSF, 60 µg mL-1 soybean trypsin inhibitor, 10 µg mL-1 leupeptin). Both nuclear and 
non-nuclear fractions were centrifuged (1250 µg, 10 min, 4°C) for further purification. 
Lysis of cells and integrity of nuclei were confirmed by light microscopy with trypan 
blue exclusion. Nuclei in relaxation buffer were disrupted by sonication (3 ×5 s). 
 
3.3.1.3 Western blotting 5-LO analysis 
Protein concentration and western blotting were performed as previously described (see 
paragraph 3.2.2.8). After electroblot to nitrocellulose membrane (Whatman Protran, 
Dassel, Germany), membranes were blocked with 0.05% PBS/Tween containing 5% 
BSA for 2 h at room temperature. Membranes were washed and then incubated with 
!                                                                                      3.0 Materials and Methods !
 
!
!
35!
primary antibody overnight at 4°C. 5-LO (AK-7, 1551, affinity purified, Karolinska 
Institutet, Stockholm, Sweden) and β-actin (Cell-Signalling, Aurogene, Rome, Italy) 
antibodies were used as 1:1000 dilution. After the incubation, the membranes were 
washed six times with 0.1% PBS-Tween and were incubated for 1.5 h at room 
temperature with horseradish peroxidase-conjugated anti-rabbit and anti-mouse 
secondary antibodies diluted 1:10000 in 0.1% PBS-Tween containing 5% non-fat dry 
milk. The membranes were washed and protein bands were detected by an enhanced 
chemo-luminescence system. 
 
3.3.2 Human neutrophils   
 
3.3.2.1 Isolation and stimulation of human neutrophils 
 
Leukocyte concentrates, prepared from freshly withdrawn peripheral blood of healthy 
adult human donors who had not taken any anti-inflammatory drugs for the last 10 days, 
with consent, were obtained from the Institute of Transfusion Medicine at University 
Hospital Jena, Germany. Neutrophils were isolated as previously described (Pergola et 
al., 2008). In brief, neutrophils were isolated from leukocyte concentrate with a multi step 
procedure: 1) dextran sedimentation; 2) centrifugation on Nycoprep; 3) hypotonic lysis of 
erythrocytes. Finally, neutrophils were suspended in ice-cold PBS containing 0.1% 
glucose (PG buffer) and counted by Vi-CELL™ XR. For PG production, 5x106 
neutrophils, from female and male donors, respectively, were suspended in PG buffer 
containing 1mM CaCl2 (PGC buffer) and stimulated with 0.5 µM A23187 (4 hours 37°C) 
in presence or absence of 10 µM AA. Then, neutrophils were stimulated with 0.5 µM 
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A23187 (4 hs 37°C) after a pre-treatment with 30 nM Mk886 (15 min 37°C). In other set 
of experiments, cells were stimulated with 10 µM AA (10 min 37°C).The reaction was 
stopped on ice and samples were centrifuged (12,000 xg/5min/4°C), PGE2 levels in the 
supernatants were measured with ELISA kit (BIOTREND, Germany). 
 
3.4 Statical analysis 
The results are expressed as mean ± standard error (SE) of the mean of n observations, 
where n represents in vivo the number of animals whether in vitro the number of 
experiments performed on different days. Triplicates were used for the various in vitro 
treatment conditions. In the western blot, the figures shown are representative of at least 
three experiments.  
For the statistical evaluation of the data Student´s t test for paired observations was 
applied. A p value <0.05 (*), <0.01 (**) or <0.001 (***) was considered significant. 
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4. RESULTS!
4.1 Sex–dependent LT biosynthesis and related inflammatory reactions in 
zymosan-induced peritonitis in mice: in vivo and in vitro analysis 
(Data of this thesis have been published: “Pharmacological Research 87 (2014): 
1-7” Rossi A., Pergola C., Pace S., Rådmark O., Werz O., Sautebin L.)  
 
LTs are lipid mediators involved in several autoimmune-inflammatory diseases. 
They are produced during the early phase of the inflammation and are essentially 
responsible for the increase of the vascular permeability (cys-LT) and the recruitment 
of the inflammatory cells (LTB4) (Kolaczkowska et al., 2002).  
 
4.1.1 In vivo evaluation of inflammatory reaction and LT biosynthesis 
4.1.1.1 Sex differences in inflammatory reaction: vascular permeability 
 
Intraperitoneal injection of zymosan resulted in an increased vascular 
permeability as one of the primary steps initiating inflammation leading to 
plasma leakage and swelling (Kolaczkowska et al., 2002). A similar time-
course in the increase of vascular permeability in male and female with a 
peak at 60 min is evident (Fig. 5). However, significant (p<0.05 n=8 at 30 
and 60 min) sex-dependent difference was observed in the amount of dye 
extravasation that was higher in female vs male mice, particularly at 30 and 
60 min after zymosan challenge (Fig. 5). 
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Fig.5 caption. Sex-dependent differences in vascular permeability in 
zymosan-induced peritonitis in mice. Mice were treated with zymosan (i.p.) 
and sacrificed at the indicated time points. Time zero (T0) corresponded to untreated 
mice. Values represent means ± S.E.M; n=8 mice; °°p<0.01; °°°p<0.001 female vs 
female T0; **p<0.01; ***p<0.001 male vs male T0; #p<0.05; ##p<0.01 female vs 
male  
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4.1.1.2 Sex differences in inflammatory reaction: leukocyte recruitment in the 
peritoneal cavity  
 
After the induction of the peritonitis there is a time-dependent increase of the 
afflux of leukocyte in the peritoneal cavity (Cash et al., 2009). In fact, the cell 
recruitment (Fig. 6A) under the effect of the released chemo-attractive factors 
(i.e. LTs) became significant at 120 min (from 1.24 x106 ± 0.09 of cell in the 
cavity at time zero to 2.26 x106 ± 0.36 at 120 min after zymosan for female, 
p<0.05, n=10-8; and from 1.35 x106 ± 0.11 of cell in the cavity at time zero to 
2.84 x106 ± 0.42 at 120 min after zymosan for male, p<0.05, n=10-8) and 
reached a peak at 240 min (p<0.001, n=16 for both sexes). Interestingly, at 
the time-peak the number of peritoneal cells was significantly (p < 0.05) 
higher in female (13.01 x106 ± 1.17 cell in the cavity of female mice and 9.87 
x106 ± 0.82 in the cavity of male) than in male mice, which was accompanied 
by an higher MPO activity (measured as neutrophil marker) in female  
(4.340±0.270 UmL-1, n=12 female; 3.220±0.290 UmL-1, n=13 male; p < 0.01 
Fig. 6B).  
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Fig.6 caption. Sex-dependent differences in peritoneal cell influx (A) and 
MPO activity (B) in zymosan-induced peritonitis in mice. Mice were treated 
with zymosan (i.p.) and sacrificed at the indicated time points. Time zero (T0) 
corresponded to untreated mice. Values represent means ± S.E.M;  (A) n=10 
mice/T0;15 min; n=13 mice/30 min; n=13-15 mice/60 min; n=8 mice/120 min; 180 
min for cell influx; n=16 mice/240 min; (B) n=12 mice/240 min. °p<0.05; °°p<0.01; 
°°°p<0.001 female vs female T0; *p<0.05; **p<0.01; ***p<0.001 male vs male T0; 
#p<0.05; ##p<0.01 female vs male  
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4.1.1.3 Sex differences in LT production in the peritoneal exudate 
 
First, the time-course of LTC4 production which represents the main 
metabolite of 5-LO (Kolaczkowska et al., 2002; Rao et al.,1994)  in the 
peritoneal exudate following zymosan challenge was evaluated. In both sexes 
there was a slight increase in  the first 15-30 min after zymosan injection, 
with a rapid decrease after 60 min.  Though the similar kinetic, LTC4 levels 
were higher in the exudate from female mice (15 min: 149.78 ± 21.49 ng mL-
1 n=15 for female and 67.64 ± 20.06 ng mL-1 n=14 for male, p<0.01; 30 min: 
137.48 ± 19.16 ng mL-1 n=13 for female and 63.75 ± 15.01 ng mL-1 n=11 for 
male, p<0.01; 60 min: 47.04 ± 10.4 ng mL-1 n=14 for female and 20.79 ± 
4.18 n=13 for male, p<0.05 Fig. 7A).  
Due to the important chemo attracting action of LTB4 its levels were 
measured as well in the exudates. As expected its production  was much more 
lower compared to LTC4 and interestingly the kinetic different. In particular, 
after zymosan injection there was a biphasic trend in LTB4 release with a 
significant (p<0.01) sex-difference during at  30 min  (30 min: 0.293±0.032 
ng mL-1 n=13 for female and 0.149±0.0310 ng mL-1  n=11 for male). No sex 
differences were found in the late increase (120-180 min) of LTB4 (Fig.7B). 
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Fig.7 caption. Sex-dependent differences in LT biosynthesis in zymosan-
induced peritonitis in mice. (A, B) Mice were treated with zymosan (i.p.) and 
sacrificed at the selected time points. Time zero (T0) corresponded to untreated 
mice. Values represent means± S.E.M; n=8 mice/T0; n=14-15 mice/15 min; n=11-14 
mice/30 min; n=13-14 mice/60 min; n=8 mice/120 min, 180 min and 240 min. 
°°p<0.01; °°°p<0.001 female vs female T0; *p<0.05; **p<0.01; ***p<0.001 male vs 
male T0; #p<0.05 female vs male at time 60 min; ##p<0.01 female time 15 and 30 vs 
male time 15 and 30.  
0 30 60 90 120 150 180 210 240
0
50
100
150
200
MALE
FEMALE
**
***
°°°
°°°
°°°
°°
°°° °°°*
** ***
##
##
#
**
Time (min)
LT
C
4 (
ng
 m
L-
1 )
0 30 60 90 120 150 180 210 240
0.0
0.1
0.2
0.3
FEMALE
MALE
##
***
**
°° °
°°°
°°°
°
* *
***
1
2
3
4
Time (min)
LT
B 4
 (n
g 
m
L-
1 )
! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!4.0!Results!!
 
!
!
43!
 4.1.1.4 Effect of circulating sex hormones on LT biosynthesis 
In order to evaluate the effect of the male sex hormones on LT production in 
zymosan-induced peritonitis, gonads from adult male mice were surgically 
removed. Five weeks after this procedure the levels of testosterone in 
operated mice (ORCH: 0.050 ± 0.006 ng mL-1 n=9) were similar to the levels 
in female mice (female: 0.055 ± 0.008 ng mL-1 n=10) and both significantly 
(p<0.05) lower than un-operated male mice (Sham male: 2.00 ± 0.7 ng mL-1 
n=9) (table 1). Lower levels of testosterone in ORCH mice than in sham 
male mice corresponded to significant (p<0.05) higher levels of LTC4 (Sham 
male: 91.70±15.6 ng mL-1; ORCH: 280.00±74.70 ng mL-1 Fig. 8A) and LTB4 
at 15 min (Sham male: 0.185±0.028 ng mL-1; ORCH: 0.290±0.032 ng mL-1). 
Orchidectomized mice showed levels of LT similar to female (female: LTC4 
200.3±40.9 ng mL-1 n=8; female: LTB4 0.275±0.03 ng mL-1 n=7) suggesting 
a negative role of testosterone in the production of these metabolites (Fig. 
8B). 
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Values represent mean± S.E.M; n=9-10 mice/group. *p<0.05 ORCH vs male sham 
 
 
 
 
 
 
 
 
! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!4.0!Results!!
 
!
!
45!
 
A 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
Fig.8 caption. Effects of orchidectomy on LT biosynthesis in zymosan-
induced peritonitis in mice. ORCH and sham-operated mice were sacrificed at 
15 (LTC4, A) and 30 min (LTB4, B) after zymosan (i.p.) treatment, respectively. 
Values represent mean± S.E.M; n=8-9 mice/time. *p<0.05 ORCH vs male sham. 
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 4.1.1.5 In vivo effect of testosterone on LT production  
To better understand the negative role of testosterone on LT biosynthesis, 
adult female mice were pre-treated with testosterone (0.5 mg kg-1 5α-DHT in 
2% DMSO) or vehicle (2% DMSO in saline) 30 min before the zymosan 
injection.  The time course of LTC4 production showed a significant 
(p<0.001) reduction at 30 min (vehicle: 0.343±0.105 LTC4/PGB1;! 5α-DHT 
0,5 mg/kg 0,261±0,0339 LTC4/PGB1; n=5) in female mice pre-treated with 
testosterone compared to female mice treated  with vehicle (Fig.9 ). 
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Fig.9 caption. Effects of 5α-DHT pre-treatment on LTC4 biosynthesis in 
zymosan-induced peritonitis in female mice. 5α-DHT and vehicle pre-treated 
female  mice were treated with zymosan (i.p.) and sacrificed at the selected time 
points. Time zero (T0) corresponded to untreated mice. Values represent mean± 
S.E.M; n=5 mice/time. °°°p<0.05 5α-DHT female mice vs vehicle. 
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4.1.2 In vitro investigation of sex differences in LT biosynthesis 
4.1.2.1 Sex differences in LT production in PM 
During the first 60 minutes after zymosan injection PM are the cell 
responsible for LTC4 production (Kolaczkowska et al., 2002; Rao et al.,1994) 
thus we collected these cells in order to investigate in vitro the reason for the 
in vivo observed sex difference. First, to confirm the sex difference in LTC4 
production in vitro, we stimulated PM in suspension (collected at 4°C to keep 
the in vivo statement) with zymosan (13 particles/cell corresponding to the in 
vivo condition, 30 min 37°C) or with A23187 (2.5 µM , 15 min 37°C).  After 
stimulation, PM from female produced significant higher levels of LTC4 
compared to PM from male, treated side-by-side with A23187 (female: 
204,8±20,9 ng mL-1; male:! 123,1±14,6 ng mL-1 p<0.05 n=4 Fig. 10A) or 
zymosan (female: 21.3±1 ng mL-1; male:!8,5±0,6 ng mL-1;!p<0.01 n=2 Fig. 
10B). The observed sex difference was not present in PGE2 release after 
stimulation with both stimuli (Fig. 11A,B) excluding that the observed sex 
difference in LTC4 formation was dependent to a diverse AA release from the 
cells as well as that sex difference involved also the COX pathway in PM. 
Next, we analyzed if the difference in the LTC4 production between activated 
female and male PM was accompanied by different 5-LO protein levels or 
subcellular localization. Intriguingly, while the basal 5-LO protein expression 
was not different between sexes (OD 5-LO/β-actin female: 1±0,05; male: 
0,96±0,05; n=3 Fig. 12A), a difference in 5-LO subcellular localization was 
evident. In fact, 5-LO was found mainly in the non-nuclear fraction of un-
stimulated PM from female mice (OD 5-LO/β-actin % of female:!78,6±3,64; 
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n=4) whereas in PM from male mice (isolated and treated side-by-side with 
female PM) 5-LO was equally expressed in both the non-nuclear and in the 
nuclear fraction of resting cells (OD 5-LO/β-actin % of male: 21,4±3,64; 
n=4), indicating a sex-dependent localization of the 5-LO enzyme. The 
stimulation of PM with A23187 (Fig. 12B) and zymosan (Fig. 12C) induced 
the translocation of cytoplasmic 5-LO to the nuclear fraction in both sexes 
being however the migrated active fraction in male lower than in female . 
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Fig.10 caption. Sex-dependent differences in LTC4 biosynthesis in mouse 
peritoneal macrophages. LTC4 formation in resident PM induced by (A) A23187 
(2.5 µM; 15 min, 37°C) or (B) zymosan (13 particles cell-1; 30 min, 37°C). Data are 
expressed as means ± S.E.M from n=4 (A23187) or n=2 (zymosan) independent 
experiments performed in triplicates, each. #p<0.05; ##p<0.01 stimulated PM from 
female vs stimulated PM from male mice.  
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Fig.11caption. PGE2 biosynthesis in mouse peritoneal macrophages is not 
sex-dependent. PGE2 formation in resident PM induced by (A) A23187 (2.5 µM; 
15 min, 37°C) or (B) zymosan (13 particles cell-1; 30 min, 37°C). Data are expressed 
as means ± S.E.M from n=4 (A23187) or n=2 (zymosan) independent experiments 
performed in triplicates, each.  
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
A23187 -       -          +      +
FEMALE
MALE
PG
E 2
(n
g 
m
L-
1 )
0
1
2
3
4
5
6
7
8
zymosan -       -         +      +
MALE
FEMALE
PG
E 2
(n
g 
m
L-
1 )
! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!4.0!Results!!
 
!
!
52!
A 
 
 
B 
 
 
C 
 
Fig.12caption. 5-LO protein expression and subcellular localization (A) 5-
LO protein expression in resident PM was analyzed by immunoblotting of total cell 
lysates. Results are representative of 3 independent experiments. (B, C) Subcellular 
localization of 5-LO in resident PM from female and male mice induced by A23187 
(2.5 µM; 15 min, 37°C) or zymosan (13 particles cell-1; 30 min, 37°C) analyzed by 
immunodetection of 5-LO in the nuclear (Nuc) and non-nuclear (Non-N) fractions of 
mild-detergent (0.1% Nonidet P-40)-lysed cells. Data are representative of 2-4 
independent experiments. 
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 4.1.2.2 Effect of sex hormones on LT production in PM 
Primarily, to evaluate the role of sex hormones in the sex-dependent 
production of LTC4 in PM, we pre-treated the cells from female mice with 
5α-DHT (10 nM; 30 min, 37 ◦C Fig.13A), and the cells from male mice with 
or 17β-estradiol (100 nM; 30 min, 37 ◦C Fig.13B). After A23187 stimulation, 
no significant effect of sex hormones in LTC4 production was found. To 
confirm the hypothesis that the sex difference was due to the in vivo actions 
of male reproductive steroid hormones, we collected PM from ORCH mice 
and sham mice. After stimulation with A23187 (2.5 µM; 15 min, 37 ◦C), PM 
from ORCH produced a significant (p<0.05) (sham male: 56,90±1,45 ng mL-
1; ORCH: 73,50±4,40 ng mL-1; n=3 Fig.13C) higher amount of LTC4 
compared to PM from sham male mice.  
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Fig.13 caption. Effects of hormones on LTC4 production in stimulated-
peritoneal macrophages from male mice. LTC4 formation in resident PM from 
(A)female and (B)male mice in vitro pretreated with hormones. (C) LTC4 formation 
in resident PM from orchidectomized (ORCH) and sham-operated mice induced by 
A23187 (2.5 µM; 15 min, 37°C). Data are expressed as means ± S.E.M from n=3 
independent experiments performed in triplicates, each. *p<0.05, stimulated PM 
from ORCH mice vs stimulated PM from sham male mice 
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4.2 Sex–dependent PG biosynthesis and related inflammatory diseases in 
different models of acute inflammation: 
As reported above, accumulated clinical evidences show that several inflammatory 
diseases are sex-biased.  Similarly to what reported for LTs, PGs play a pivotal role 
in several disorders such as circulating shock (Schröder et al., 1998) or ulcerative 
colitis (Tragnone et al., 1996). Interestingly, in these diseases, male present higher 
severity and incidence. However, to date,  little is known about sex difference in PG 
production, and this prompted us to study PG production in both sexes by the use  of 
selected experimental  models of acute inflammation. 
 
4.2.1 In vivo evaluation of inflammatory reaction and PG biosynthesis 
4.2.1.1 Sex-dependent differences in PG biosynthesis in zymosan-induced 
peritonitis in mice 
Zymosan injection resulted in a marked production of PGs in the peritoneal 
exudates of male and female mice. Both sexes presented the same kinetics in 
PG production. There were no sex differences in PGE2 production during the 
first hour, while it occurred in the late phase of the inflammatory reaction 
sustained by neutrophils (Cash et al., 2009) starting at 60 minutes and 
becoming significant (male: 1,69±0,155 ng mL-1 n=29; female: 1,09±0,108 
ng mL-1 n=28; p<0.01 Fig.14) at 240 min.   
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Fig.14 caption. Sex-dependent differences in PGE2 biosynthesis in 
zymosan-induced peritonitis in mice. Mice were treated with zymosan (i.p.) 
and sacrificed at the selected time points. Time zero (T0) corresponded to untreated 
mice. Values represent means± S.E.M; n=23 mice/T0; n=24 mice/15 min; n=24 
mice/30 min; n=25 mice/60 min; n=12 mice/120 min, n=11 180 min and n=29 240 
##p<0.01 male time 240 min vs female time 15 time 240 min.  
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 4.2.1.2 Sex-biased PG biosynthesis in carrageenan-induced pleurisy in rats 
Next, we analyzed if the observed sex difference in PG production was 
species-specific. To this aim we utilized a well known model of acute 
inflammation, carrageenan-induced pleurisy in rats, where PGs play a pivotal 
role (Moore et al., 2010). The injection of carrageenan induced a time-
dependent production of PGs in the thoracic cavity starting after 120 min with 
a peak at 240 min and a decrease in the next 480 min, but still higher than the 
control animals. Significant (p<0,05) higher PGE2 levels were found in the 
pleural exudates of male rats compared to the female (male 4 hours: 
1.180±0.110 ng mL-1 n=6; female 4 hours: 0.8600±0.090 ng mL-1 n=6; male 
8 hours: 0.377±0.055 ng mL-1 n=6; female 8 hours: 0.2230±0.0280 ng mL-1 
n=6 Fig.15) in the late times of the inflammatory response.  
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Fig.15 caption. Sex-dependent differences in PGE2 biosynthesis in 
carrageenan-induced pleurisy in rats. Rats were treated with carrageenan by 
an intrapleural injection and sacrificed at the selected time points. Time zero (T0) 
corresponded to untreated rats. Values represent means± S.E.M; n=6 mice/T0; n=13 
rats/2 hours; n=6 rats/4 hours ; n=6 rats/8 hours. #p<0.05 male time 4 and 8 hours vs 
female time 4 and 8 hours.  
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4.2.1.3 Sex difference in PG related-disease: the mouse PAF-induced 
mortality 
Clinical studies show that circulating-shock induced mortality in human has 
an higher incidence in male compared to female (Schroeder et al, 1998). 
Interestingly, Becker and colleagues demonstrated the pivotal role played by 
PGs in PAF-induced mortality in mice. On these bases, we selected PAF-
induced mortality as third model of acute inflammation to evaluate the PG-
mediated sex difference. PAF injection caused a dose-dependent death in 
mice during the 2 hours of observation with sex-biased difference. The 
administration of PAF at the dose of 100 µg/kg resulted in a significant 
higher mortality in male mice compared to the female (p value= 0,001; 90% 
of deaths 27 out 30 male; 52% of deaths 15 out 29 female).   The sex 
difference was abolished by the higher dose of 200 µg/kg of PAF (88% of 
deaths 43 out 49 male; 75% of deaths 43 out 57 table 2). 
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Table 2 caption. Sex difference in mouse PAF-induced mortality. Mice were treated 
i.v. with PAF (30 µg/kg; 100 µg/kg; 200 µg/kg) and observed for 2 hours. p value results 
from Fisher’s exact test one tailed. 
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4.2.2 In vitro evaluation of PG biosynthesis  
4.2.2.1 Capacity of PGE2 production in human neutrophils is sex-dependent 
and receptor-independent 
Neutrophils are the immune cells involved in the late phase of the 
inflammatory reaction, which are recruited in the inflammation site by 
chemo-attractant factors (i.e. LTB4, Yokomizo  et al., 1997) produced by the 
resident cells (Dimasi et al., 2013). To investigate a) the reason of the 
observed sex difference in PGE2 production in the late phase of inflammation 
and b) in order to study if this difference is present also in human species, we 
isolated neutrophils from the blood of female and male donors and stimulated 
them with 0.5 µM A23187 to skip any receptor involvement.  After in vitro 
stimulation with 0.5 µM A23187 (37°C; 4 hours), PGE2 production was 
significantly (p<0.05) higher in male compared to female (male: 1250±127 
pg mL-1; female: 746±53.5 pg mL-1; n=3 Fig. 16A). The addition of 
exogenous AA abolished the sex difference suggesting that this effect was 
due to the conversion of the endogenous substrate, the AA (male: 711±190 pg 
mL-1  ; female: 684±116 pg mL-1 Fig. 16B).  
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Fig.16 caption. Sex differences in PGE2 biosynthesis in human 
neutrophils. PGE2 formation in human neutrophils induced by (A) A23187 0.5 µM 
and (B) A23187 0.5 µM + AA 10 µM (37°C). Data are expressed as means ± S.E.M 
from n=3 independent experiments performed in triplicates, each. #p<0.05, male vs 
female, t-test. 
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4.2.3 Effect of 5-LO pathway inhibition on AA metabolism via COX enzymes 
a) In vitro : human neutrophils 
On the basis of the existent sex difference in arachidonic acid metabolism by 
5-LO enzyme in human neutrophils leading to a higher production of LTs in 
female (Pergola et al., 2008), , we hypothesized that this event could have 
been responsible for the observed PGE2 sex diverse biosynthesis (higher in 
male). Thus, we shifted the AA metabolism through the COX pathway by a 
pre-treatment of the cells with MK886 (30 nM 15 min 37°C), a FLAP 
inhibitor. After that, neutrophils were stimulated with 0.5 µM A23187 (4 
hours, 37°C) for PGE2 production. The blockage of 5-LO enzyme did not 
affect PGE2 production in male neutrophils while significantly (p<0.01) 
increased the female levels, abolishing the sex difference (male DMSO: 
786±144 pg mL-1 ; male MK886: 835±67 pg mL-1 ; female DMSO: 448±54,5 
pg mL-1 ; female MK886: 1094±225 pg mL-1 n=3 Fig. 17A) .  
b) In vivo: in carrageenan-induced pleurisy in rats 
To correlate the in vitro data on human neutrophils with the in vivo data, we 
pre-treated rats with MK886 (1,5 mg/kg, 30 min before pleurisy induction). 
Also in vivo MK886 was able to increase significantly (p<0,05) PGE2 
production only in female rats and to abolish the sex difference (male DMSO: 
1.087±0.061 ng mL-1; male MK886: 1.089±0.1 ng mL-1; female DMSO:!
0.881±0.057  ng mL-1; female MK886: 1.18±0.12 ng mL-1 Fig.17B). 
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Fig.17 caption. Effect of MK886 pretreatment on PGE2 biosynthesis. 
PGE2 formation in human neutrophils induced by (A) A23187 0.5 µM in male and 
female neutrophils pre-treated with MK886 and (B) in carrageenan-induced pleurisy 
in rats pretreated with MK886 . Data are expressed as means ± S.E.M from (A) n=3 
independent experiments performed in triplicates, each or n=28-6 rats ##p<0.01, 
#p<0.05male vs female, °° p<0.01, °p<0.05 untreated female vs mk886 treated 
female. 
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5. DISCUSSION 
The scientific community is more and more interested in the sex differences in the 
inflammatory/immune diseases (Whitacre CC., 2001), but little is known to date 
about the mechanisms involved. In this thesis we have investigated the sex 
differences in eicosanoid biosynthesis, pivotal mediators in several 
autoimmune/inflammatory disorders with a well known sex bias, such as asthma 
(Osman M, 2003), multiple sclerosis (Khalid R., 2014) or sepsis shock (Schroeder J 
et al., 1998). Eicosanoid biosynthesis starts with the release of AA from the 
membrane phospholipids through the action of cPLA2 then, the free AA can be 
substrate of different pathways and among them the 5-LO activity leads to the 
formation of LTs whereas COX activity to the formation of prostanoids. These 
processes can be regulated by different factors and recently sex has been addressed 
as one of them. In particular, Pergola and colleagues have shown that LT 
biosynthesis in human whole blood as well as in human immune cells (i.e. 
monocytes and neutrophils) is higher in female than male. This difference was due to 
the ability  of testosterone to regulate 5-LO subcellular localization (neutrophils) or 
its activation status (monocytes) (Pergola et al., 2008; Pergola et al., 2011). In this 
thesis we show for the first time, that the sex difference in eicosanoid biosynthesis is 
present also in in vivo models of acute inflammation.  
First, it was evaluated if the observed sex difference in LT biosynthesis was 
present also in an in vivo model of acute inflammation related to LTs such as  
zymosan-induced peritonitis in mice (Rao et al., 1994). After peritonitis induction, 
LTC4 and LTB4 levels were significantly higher in the inflamed peritoneum of 
female than male mice, which was followed and/or accompanied by sex differences 
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in relevant inflammation parameters measured in terms of vascular permeability and 
neutrophil infiltration. In particular, vascular permeability represents one of the 
primary steps in the inflammatory reaction that is a prerequisite for the leakage of 
plasma into the inflamed tissue. The i.p. injection of zymosan in mice induced an 
inflammatory reaction characterized by early vascular permeability and steady 
increase of protein leakage into the peritoneum in the first 60 min. Interestingly, 
these events were more robust in female than in male mice, implying a more 
pronounced inflammatory response in female animals. Vascular permeability 
represents, however, a highly regulated multistep process mediated by inﬂammatory 
mediators, and cys-LTs are particularly recognized as potent vascular-regulating 
agents through the interaction with the cysLT1 receptor (Griswold et al., 1991; 
Maekawa A. et al., 2002). We observed that LTC4 levels rapidly raised after zymosan 
injection (peaking at 15-30 min) and were significantly higher in female mice, 
suggesting that the sex differences in vascular permeability could be due, at least in 
part, to the different LT biosynthesis. Previous studies showed that the dominant 
peritoneal leukocyte population in the early phase of the inflammatory response in 
CD1 mice are the resident macrophages (about 95%, Doherty et al., 1985), which are 
known to mainly synthesize LTC4 as 5-LO product (Kolaczkowska et al., 2002; Rao 
et al., 1994). In fact, it has been reported that macrophage depletion caused a 
profound decrease of LTC4 production and vascular permeability in zymosan-
induced peritonitis (Kolaczkowska et al.,2002). Moreover, cell numbers as well as 
MPO activity in the peritoneum (which is an index of neutrophil infiltration, another 
LT-related event) were significantly higher in female than in male mice after 240 
min. Supporting the delayed cell recruitment in the peritoneal cavity, LTB4 levels 
were found higher in the peritoneal cavity of female mice 15 minutes after the 
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zymosan injection, suggesting that the sex-difference in LT biosynthesis was due to 
the resident peritoneal cell stimulated by zymosan.  
Previous studies demonstrated that the lower production of LT in male human 
immune cells such as neutrophils and monocytes (Pergola et al., 2008; Pergola et 
al., 2011) was due to the ability of testosterone to regulate 5-LO subcellular 
localization (in neutrophils) or its activation status (in monocytes) leading to a the 
sex-biased LT formation. On these bases, the effect of testosterone was investigated 
also in our in vivo model. First, to understand the role of this sex hormone on LT 
biosynthesis, we surgically removed the gonads from male mice and induced the 
peritonitis five weeks after (time necessary to deplete testosterone levels in the blood 
and to obtain the turnover of peritoneal resident cells). Interestingly, the higher 
production of LT in orchidectomized mice compared to the sham one accompanied 
by a lower plasma testosterone levels, led us to hypothesize that the circulating male 
hormone was responsible also  for the in vivo sex difference in LT biosynthesis. 
Supporting this theory, the pre-treatment of female mice with testosterone 
significantly reduced LT levels in the exudates after peritonitis induction. Then, PM 
were selected as in vitro model to investigate the reason behind this sex differences 
because has been previously reported that in CD1 mice resident peritoneal cells are 
95% macrophages (Kolaczkowska et al.,2002) and the higher production of LTC4 in 
female PM after A23187 and zymosan stimulation strongly supported this choice. 
The absence of a sex difference in LT biosynthesis after in vitro pre-treatment of PM 
with hormones as well as the higher production of LTC4 in PM from 
orchidectomized mice support the role of the circulating testosterone in the whole 
organism. In human cells the inhibitory activity of testosterone was related to a lack 
in 5-LO enzyme activity strictly connected to its subcellular localization. 
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Intriguingly, a substantial sex difference was found in 5-LO subcellular localization 
in PM from male and female mice according to the previous findings in human 
neutrophils (Pergola et al., 2008). In fact, the higher levels of 5-LO enzyme in the 
nuclear fraction of unstimulated male PM resulted in a lower trafficable 5-LO 
enzyme leading to less LT production. Interestingly, no sex differences were found 
in the total expression of 5-LO enzyme. Note that the levels of the COX-derived 
PGE2 were instead equal in PM from male and female mice as well as in the first 60 
minutes after zymosan injection where the PM are the cells responsible for its 
production. Surprisingly, a sex-biased PGE2 formation was found in the late phase of 
the inflammatory response. In particular, 2 hours after peritonitis induction, a trend in 
higher production of PGE2 from male mice was evident and it became significant at 
4 hours. Interestingly, starting from 2 hours after the zymosan injection, there was a 
significant increase of the cell afflux in peritoneal cavity of both sexes that raised a 
peak at 4 hours where the cell population is mostly composed by infiltrated 
neutrophils, as confirmed by MPO levels. Notably, the same events were present in 
another model of acute inflammation such as carrageenan-induced pleurisy in rats. In 
fact, after carrageenan injection, a time-dependent production of PGE2 with a peak at 
4 hours was evident and, interestingly, with a similar kinetic for both sexes. 
According to the peritonitis data, higher levels of PGE2 were present in male rat 
exudates in the late phase of the inflammatory reaction, measured (4 and 8 hours 
after pleurisy induction), mainly  supported  by neutrophils as shown by Mathieu J. 
and colleagues (Mathieu J. et al., 1990).  
Moreover, higher mortality in male mice after PAF-induced shock strictly 
highlighted the higher capability of male neutrophils to produce PGs. In fact, as 
previously shown ( Becker et al., 1993 and  Xiaoming et al., 1991), inhibition of PG 
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production as well as neutrophil depletion both decrease the PAF- induced mortality 
in mice.  
The in vivo evidence of the sex biased PG production by neutrophils represents an 
important finding in the light of the clinical outcomes that show that several 
inflammatory disorders in which PGs play a pivotal role (i.e ulcerative colitis or 
sepsis) have an higher incidence in male compared female (Tragnone et al., 1996; 
Schroeder et al., 1998). Since neutrophils represent the cells present in the 
inflammatory infiltrate, in order to investigate if the sex difference in PG 
biosynthesis is present also in human, a dextran-based method combined with a 
differential centrifugation on Nycoprep cushions was used for the isolation of 
neutrophils from blood of female and male donors (Pergola et al., 2008). To induce 
PGE2 production we selected calcium ionophore in order to skip the receptor 
involvement in the possible sex bias in the light of previous findings showing an 
higher expression of toll-like receptor 4 in male neutrophils as well as their higher 
susceptibility to interferon gamma stimulation (Aomatsu et al., 2013) . After 
stimulation, male neutrophils produced higher levels of PGE2 than female. 
Interestingly, this sex difference was abolished by the addition of exogenous AA. 
Taking together these two data highlight the diverse AA metabolism by the two 
sexes, independently from receptor involvement. As mentioned above, AA can be 
metabolized either by COX for prostanoid biosynthesis or by 5-LO for LT 
production. On the basis of the existent sex difference in 5-LO product formation in 
male and female neutrophils (higher in females) (Pergola et al., 2008), we have 
hypothesized that the diverse production of PGE2 could strictly depend on AA shunt 
from 5-LO to COX enzymes. In particular, the blockage of 5-LO activity by pre-
treatment with Mk886, a FLAP inhibitor, increased PGE2 formation in female cells, 
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abolishing the sex difference. These data support the theory that the sex difference in 
PGE2 production was due, at least in part, to the already shown sex-biased 
metabolization of AA via 5-LO, being the production of LTs higher in female than in 
male. The low enzymatic activity of 5-LO in male, due to the different subcellular 
localization, enhances the substrate availability for COX leading to a higher 
production of PGE2. Intriguingly, this conclusion was supported by the in vivo 
abolishment of the sex difference in PGE2 biosynthesis in rats after Mk886 pre-
treatment in the pleurisy model. 
The results of this thesis clearly demonstrate that sex is an important factor 
that influences inflammation independently from the stimuli or species. and that it 
should  be considered   in  the development of therapeutic strategy  to achieve  a sex-
tailored treatment of sex-biased diseases.  
!
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APPENDIX 1: ABBREVIATIONS 
 
AA arachidonic acid 
BSA bovine serum albumine  
Ca-ion calcium-ionophore A23187 
CaMK Ca2+ /calmodulin-dependent protein  
CLP  coactosin-like protein 
COX cyclooxygenase 
cPLA2 cytosolic phospholipase A2  
CYP cytochrome p450 
cys-LT cysteinyl leukotriene 
CVD cardiovascular diseases 
DAG  diacylglycerol  
DBD DNA binding domain 
DHT dihydrotestosterone 
DMSO  dimethyl sulfoxide 
EAE Experimental Autoimmune Encephalomyelitis 
EDTA ethylenediamine-tetraacetic acid  
EPA 5,8,11,14,17-eicosapentaenoic 
ERK extracellular signal-regulated kinase 
FLAP  5-lipoxygenase activating protein 
GPCR G-protein coupled receptor 
HETE hydroxyeicosatetraenoic acid 
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12-HHT 12-hydroxy-5,8,10-heptadecatrienoic acid 
HpETE hydroperoxy-6-trans-8,11,14-cis-eicosatetranoic acid  
IP3 inositol 1,4,5-trisphosphate and diacylglycerol (DAG)   
LM lipid mediators 
LO lipoxygenase  
LPS  lipopolysaccharide Epstein Barr Virus (EBV), 
LT leukotriene  
LX lipoxins 
MAPEG membrane-associated proteins in eicosanoid-and glutathione 
metabolism 
MAPK  mitogen activated protein kinase 
MPO myeloperoxidase 
MS multiple sclerosis 
NF-κB nuclear factor-κB  
Non-N non nuclear fraction 
NP40 Nonidet P-40 
Nuc nuclear fraction 
ORCH orchidectomized mice 
O.D. optical density 
PAF platelet activating factot 
PBS phosphate buffered saline 
PC phosphatidylcholine 
PG prostaglandin 
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PGC buffer PBS-glucose-Ca+2 buffer (see materials and methods)  
PGES PGE synthase 
PGHS prostaglandin endoperoxide synthase 
PI3K  phosphatidylinositol 3-OH kinase  
PKA protein kinase A  
PKC  protein kinase C 
PL phospholipase 
PM resident peritoneal macrophages 
PMA phorbol 12-myristate 13-acetate  
PMNL  polymorphonuclear leukocytes 
PMSF phenylmethyl sulfoniyl fluoride 
PUFA polyunsaturated fatty acid 
RIA radioimmunoassay 
RA rheumatoid arthritis 
SDS sodium dodecyl sulphate 
SLE systemic lupus erythematosus 
sPLA2 secretory phospholipase A2  
UPLC-MS/MS ultra performance liquid chromatography tandem mass spectrometry 
WB western blot  
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